Skip to content

A clinical monograph on the CJC-1295 and ipamorelin research combination — read as a printed pharmacopoeia entry, not a clinic.

Engraved cobalt schematic of a long GHRH-analogue chain and a short peptide converging on a single pituitary node with a rising pulse, on slate
The short answer

What Does CJC-1295 Ipamorelin Do to Your Hormones?

It makes your body release more growth hormone, but the pair hasn't had a fair human trial.

What the pair changes in your body

What does CJC-1295 Ipamorelin do? Both peptides make your growth gland release more growth hormone. A peptide is a short row of protein building blocks. CJC-1295 keeps the gland releasing more for days. Ipamorelin briefly tells the same gland to release more. The pair may raise the hormone more than either drug alone.

People trying the pair for research say they sleep better. Some report less workout soreness or slow fat loss. Those are personal reports, not results from a controlled study. A fair human trial hasn't proved any of those claims. Neither peptide has FDA approval. No controlled human trial has tested the set blend. The effects page sorts claims from known concerns. For you, that missing trial is the fact that counts.

What happened when two hormone drugs were paired

Did two growth-hormone drugs work better together? In one study, men received two drugs that make the growth gland release hormone. The pair caused a larger rise than either drug alone [3]. Yet those men didn't receive this set blend.

Another test used cells in a dish. The cell activity tied to hormone release was about twice as high with both drugs [4]. CJC-1295 and ipamorelin act in those two separate ways. The growth hormone secretagogue page explains the long name. These separate tests make the pair seem worth studying. They don't prove that the sold blend helps people.

What each drug did by itself

What changed when each drug was tested alone? In healthy adults, one CJC-1295 shot raised growth hormone for six days or more. It also raised IGF-1, a liver-made hormone that helps cells grow. That can be a concern when cancer is present. After more than one shot, IGF-1 stayed raised as long as 28 days [1].

Ipamorelin was tested alone in pigs. Researchers tried amounts more than 200 times higher than the level that began to work. Growth hormone rose, while stress hormones didn't [2]. Tests also used GHRP-6 and GHRP-2, older drugs that raise growth hormone. Ipamorelin worked as well as GHRP-6. Still, this was a pig test, not a human one. Read the full CJC-1295 Ipamorelin research. For you, the split matters: no test gave people both drugs.

What the studies haven't proved

Do the studies prove the pair is a safe treatment? No. Neither CJC-1295 nor ipamorelin has FDA approval for human use. Both are sold for research. No checked human study has tested the ready-mixed pair [3] [4]. World sports rules ban both drugs at all times. That matters if you compete in any tested sport.

The drugs also last for very different lengths of time. A long-lasting form of CJC-1295 acts for days. Ipamorelin leaves the body within hours [1] [2]. This gap makes the blend harder to judge. The CJC-1295 Ipamorelin effects page covers reports and concerns. The CJC-1295 Ipamorelin references page names each study. You aren't reading proof of a finished treatment.